Alliqua to list on Nasdaq Capital Market on January 28 Alliqua has received approval from NASDAQ’s Listing Qualifications Department to list its common stock on the NASDAQ Capital Market. The Company anticipates that its common stock will commence trading on the NASDAQ Capital Market on January 28 under the same ticker symbol “ALQA”. Until that time, the Company’s common stock will continue to trade on the OTC Markets under the ticker symbol “ALQA”.
Alliqua BioMedical signs group purchasing agreement with HealthTrust Alliqua BioMedical announced that it has signed a national group purchasing agreement with HealthTrust. The agreement, which became effective on Jan. 1, 2016, added Alliqua's Biovance Human Amniotic Membrane Allograft to HealthTrust's regenerative tissue wound care contracting category.